Elsevier Appoints New President of Elsevier CPM Resource Center
Hajo Oltmanns to lead expansion of CPM’s clinical decision support tools
Grand Rapids, MI, April 30, 2012 – Elsevier, a world-leading provider of scientific, technical and medical information products and services, has appointed Hajo Oltmanns as the new President of Elsevier CPM Resource Center (CPM), a leader in developing clinical decision support (CDS) tools for healthcare.
Hajo will lead the continued development and expansion of CPM’s clinical decision support tools and the engagement of the CPM International Consortium, an organization composed of hundreds of CPM’s client hospitals and health systems. Hajo is also responsible for the development of Elsevier’s new Order Sets, which is expected to launch in late 2012.
Hajo’s appointment comes as CPM and our other CDS groups work together to transform healthcare,” said Jay Katzen, Managing Director, Elsevier Clinical Decision Support and Payer Solutions. “Hajo’s experience and understanding of healthcare will help grow this business, empowering our customers to achieve measureable, sustainable success through the implementation of evidence-based CDS and professional practice expertise.”
At Elsevier Health Sciences, Hajo previously served as the Senior Vice President of Strategy & Business Development, focusing on the CDS group. Hajo joined Elsevier in 2007 and served as a member of the executive strategy team, working across all international businesses units while based in Amsterdam.
Prior to Elsevier, Hajo was a manager at the Boston Consulting Group in Chicago, where he focused on strategy, development and customer understanding across several industries, including healthcare.
Originally from Germany, Hajo has an MA from the University of Edinburgh and an MBA from Northwestern University’sKellogg School of Management.About Elsevier
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).Media contact
Vice President, Global Corporate Relations, Elsevier
+1 215 239 3508